Bendamustine, Low-Dose Dexamethasone, and

Bendamustine, Low-Dose Dexamethasone, and
Lenalidomide (BdL) For The Treatment Of Patients With
Relapsed Multiple Myeloma Confirms Very Promising
Results In a Phase I/II Study
by Samantha Pozzi, Stefania Badiali, Alessandro Corso, Pellegrino Musto, Attilio
Guarini, Carla Minoia, Donatella Vincelli, Roberto Ria, Luciano Masini, Giovanni
Quarta, Massimo Gentile, Carla Mazzone, Antonio Palumbo, and Fortunato Morabito
Blood
Volume 122(21):3212-3212
November 15, 2013
©2013 by American Society of Hematology
Duration of remission.
Samantha Pozzi et al. Blood 2013;122:3212
©2013 by American Society of Hematology